AiCure has introduced OpenDBM, an open-source version of its computer vision and AI-powered digital biomarker platform. The platform’s framework will give the scientific community access to AiCure’s digital biomarker algorithms and the ability to apply them to their own datasets to measure patient responses to treatment, including facial, vocal and motor characteristics.
AiCure’s digital biomarker platform gathers and analyzes visual and auditory cues directly through a patient’s smartphone camera, pinpointing critical disease characteristics and behavioral trends. Through accurate and consistent data capture, the platform helps to ensure the integrity of clinical trial data throughout a study’s duration.
“While digital biomarkers help to eliminate the blind spots of infrequent and subjective in-person visits, their exclusivity means many in the scientific community are still flying blind when it comes to measuring the impact and validity of these proprietary algorithms, limiting their use and the weight they carry during regulatory conversations,” said Ed Ikeguchi, CEO of AiCure. “AiCure’s OpenDBM opens this black box. Through an open science framework, we hope to unleash the potential of digital biomarkers to not only safeguard the success of a trial and understanding of a drug’s impact, but also better equip sites to offer each patient the support they need.”
Read the full release, here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.